Clinical and Genetic Characteristics of 153 Chinese Patients With X-Linked Hypophosphatemia.
Clinical and Genetic Characteristics of 153 Chinese Patients With X-Linked Hypophosphatemia.
复制标题
153例中国X连锁低磷血症患者的临床和遗传特征
DOI:
10.3389/fcell.2021.617738
复制
发表时间:
2021
影响因子:
5.5
通讯作者:
Yue H
中科院分区:
文献类型:
--
作者:
Lin X;Li S;Zhang Z;Yue H
X-linked hypophosphatemia (XLH) is caused by inactivating mutations in the phosphate-regulating endopeptidase homolog, X-linked (PHEX) gene, resulting in an excess of circulating intact fibroblast growth factor-23 (iFGF-23) and a waste of renal phosphate. In the present study, we retrospectively reviewed the clinical and molecular features of 153 Chinese patients, representing 87 familial and 66 sporadic cases with XLH. A total of 153 patients with XLH presented with signs or symptoms at a median age of 18.0 months (range, 9.0 months–26.0 years). Lower-limb deformity was the most frequent clinical manifestation, accounting for 79.1% (121/153). Biochemical screening showed increased serum levels of iFGF23 in patients with XLH, with a wide variation ranging from 14.39 to 730.70 pg/ml. Median values of serum iFGF23 in pediatric and adult patients were 94.87 pg/ml (interquartile range: 74.27–151.86 pg/ml) and 72.82 pg/ml (interquartile range: 39.42–136.00 pg/ml), respectively. Although no difference in circulating iFGF23 levels between these two groups was observed (P = 0.062), the proportion of patients with high levels of circulating iFGF23 (>42.2 pg/ml) was greater in the pediatric group than in the adult group (P = 0.026). Eighty-eight different mutations in 153 patients were identified, with 27 (30.7%) being novel. iFGF23 levels and severity of the disease did not correlate significantly with truncating and non-truncating mutations or N-terminal and C-terminal PHEX mutations. This study provides a comprehensive description of the clinical profiles, circulating levels of iFGF23 and gene mutation features of patients with XLH, further enriching the genotypic spectrum of the diseases. The findings show no evident correlation of circulating iFGF23 levels with the age or disease severity in patients with XLH.
登录
查看更多内容
影响因子:
5.4
作者:
Li SS;Gu JM;Yu WJ;He JW;Fu WZ;Zhang ZL
通讯作者:
Zhang ZL
影响因子:
4.1
作者:
BinEssa, Huda A.;Zou, Minjing;Shi, Yufei
通讯作者:
Shi, Yufei
影响因子:
2.8
作者:
Hu WW;Zhang Z;He JW;Fu WZ;Wang C;Zhang H;Yue H;Gu JM;Zhang ZL
通讯作者:
Zhang ZL
DOI:
10.1016/j.bbrc.2012.06.042
发表时间:
2012-07-13
影响因子:
3.1
作者:
Kang, Qing-lin;Xu, Jia;Zhang, Zhen-lin
通讯作者:
Zhang, Zhen-lin
影响因子:
0.2
作者:
Radlovic, Vladimir;Smoljanic, Zeljko;Pavicevic, Polina
通讯作者:
Pavicevic, Polina